Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19
N/A
Provided Content: Content provided by Business Wire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
